Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
0.951
-0.029 (-2.97%)
Dec 20, 2024, 4:00 PM EST - Market closed

CNTB Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for CNTB stock has a target of 8.00, which predicts an increase of 741.31% from the current stock price of 0.95.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $8.00 $8.00 $8.00 $8.00
Change +741.31% +741.31% +741.31% +741.31%
* Price targets were last updated on Sep 6, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for CNTB is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 111111
Buy 111110
Hold 000000
Sell 000000
Strong Sell 000000
Total 222221

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$8
Strong Buy Reiterates $8 +741.31% Sep 6, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$8
Strong Buy Reiterates $8 +741.31% Jun 13, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$7$8
Strong Buy Maintains $7$8 +741.31% Apr 17, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$7
Strong Buy Initiates $7 +636.14% Mar 4, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$5
Buy Reiterates $5 +425.82% Sep 13, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
174.34M
Revenue Next Year
285.74M
from 174.34M
Increased by 63.90%
EPS This Year
-1.45
from -1.08
EPS Next Year
n/a
from -1.45
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Jan 1, 2022 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
-----174.34M285.74M224.25M
Revenue Growth
------63.90%-21.52%
EPS
-9.99-45.60-3.88-2.15-1.08-1.45--2.75
EPS Growth
--------
Forward PE
--------
No. Analysts -----444
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 179.5M 294.1M 230.9M
Avg 174.3M 285.7M 224.3M
Low 167.5M 274.5M 215.5M

Revenue Growth

Revenue Growth 202420252026202720282029
High -
68.7%
-19.2%
Avg -
63.9%
-21.5%
Low -
57.5%
-24.6%

EPS Forecast

EPS 202420252026202720282029
High -1.49 - -2.83
Avg -1.45 - -2.75
Low -1.39 - -2.64

EPS Growth

EPS Growth 202420252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.